Commercializing Living Therapies with CCRM

About Commercializing Living Therapies with CCRM

Hear from academic and industry experts sharing insider insights, information and trend forecasts for the cell and gene therapy industry. “Commercializing Living Therapies with CCRM” is brought to you by CCRM, a leader in developing, manufacturing and commercializing regenerative medicine-based technologies, and cell and gene therapies. Questions / comments? email: podcast@ccrm.ca.

Publisher

CCRM

Category

science

Language

en

Explicit

No

First episode

14 Dec 2021

Latest episode

15 Oct 2026

Latest episodes

28 episodes in the feed.

1. 

   15 Oct 2026

   From qubits to CGTs: Quantum computing’s potential in advanced therapies

   Featuring: Alán Aspuru-Guzik, PhD, Director, Acceleration Consortium, Professor of Chemistry, Professor of Computer Science, Professor of Chemical Engineering and Applied Chemistry, Professor of Materials Science and Engineering, Faculty Member, Institute of Medical Science, University of Toronto; CIFAR AI Chair, Vector Institute for Artificial Intelligence; Senior Director of Quantum Chemistry, NVIDIA Martin Roetteler, PhD, Vice President of Quantum Applications R&D, IonQ *** Quant...

2. 

   15 Sept 2026

   Breaking down barriers: Bringing advanced therapies to patients worldwide

   Featuring: Bambi Grilley, Professor at Baylor College of Medicine, President-Elect for the International Society of Cell and Gene Therapy Staci Arnold, Professor of Pediatrics at Emory University, and Pediatric Hematologist/Oncologist at the Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta *** Access to cell and gene therapies (CGTs) remains uneven around the world, particularly for patients in low- and middle-income countries (LMICs). In this episode of Comme...

3. 

   14 Aug 2026

   The CMC edge: Future-proofing cell and gene therapies for market

   Featuring: Katy Spink, President and COO, Managing Partner, Dark Horse Consulting Group Craig Beasley, Chief Technology Officer (CMC & Device), BlueRock Therapeutics *** Chemistry, Manufacturing, and Controls (CMC) is often viewed as a regulatory requirement, but could it also be one of the biggest competitive advantages for a cell or gene therapy company? In this episode, host Krista Lamb sits down with Katy Spink and Craig Beasley to explore why CMC should be considered a strategic busi...

Reach and audience

Public platform figures. Ratings count people who left a rating, not total listeners.

Spotify

5.0 / 5

3 ratings

Podcast Authority Score: 21 / 100

A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.

Quality

14

Social presence

0

YouTube

0

Engagement

68

Contact Commercializing Living Therapies with CCRM

Guest appearances

Does not typically book guests

Based on episode analysis; this does not confirm that the show is currently accepting guests.